Recent Press Releases

Increased risk of narcolepsy observed also among adults vaccinated with Pandemrix in Finland

Increased risk of narcolepsy observed also among adults vaccinated with Pandemrix in Finland 23 May 2013 Adults aged less than 65 years who had received Pandemrix-vaccine in 2009 and 2010 to protect...

OHSU research highlights promising strategy to help vaccines outsmart HIV

OHSU research highlights promising strategy to help vaccines outsmart HIV 05/24/13 Portland, Ore. Researchers at OHSU's Vaccine and Gene Therapy Institute believe they have discovered a...

Whole-cell vaccine was more effective than acellular vaccine during California pertussis outbreak

Whole-cell vaccine was more effective than acellular vaccine during California pertussis outbreak OAKLAND, Calif., May 20, 2013 — Whole-cell pertussis vaccines were more effective at protecting...

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy

Rotavirus Vaccine Developed in India Demonstrates Strong Efficacy Public-Private Partnership Announces Phase III Clinical Trial Results at Conference in Delhi Tuesday, May 14, 2013 New Delhi,...

ViS selected to present at TEDMED 2013

ViS selected to present at TEDMED 2013 -- Conference recognizes unique platform that promises to revolutionize clinical trial planning -- New approach can speed delivery of new medicines to patients...

La Jolla Institute's surprising finding could alter the face of dengue vaccine development

La Jolla Institute's surprising finding could alter the face of dengue vaccine development New data on T cells' protective role suggests need for new approach to dengue vaccine design SAN...

Medicago and IDRI Reports Positive Results for its Phase I Clinical Trial for an H5N1 Vaccine

Medicago and IDRI Reports Positive Results for its Phase I Clinical Trial for an H5N1 Vaccine - All three configurations of adjuvant and route of administration exceeded the three CHMP criteria-...

Immune Targeting Systems announces positive Phase 2a data in the at risk elderly population with Flunisyn™, its pan-strain influenza A T-cell vaccine, and two UK Biomedical Catalyst grants for Chronic Hepatitis B and Oncology

Immune Targeting Systems announces positive Phase 2a data in the at risk elderly population with Flunisyn™, its pan-strain influenza A T-cell vaccine, and two UK Biomedical Catalyst grants for...

Current HPV Vaccine May Not Help Some Women with Immune Problems

Fox Chase study finds some women with HIV become infected by cancer-causing forms of HPV that are not covered by current vaccines WASHINGTON, DC (April 7, 2013)—Women with HIV acquire...

IDRI and Medicago to present data at the World Vaccine Congress

IDRI and Medicago to present data at the World Vaccine Congress Presentation of Positive Interim Phase I Clinical Trial results for an H5N1 Vaccine with GLA Adjuvant SEATTLE and QUEBEC CITY, April 9,...

Press Release: Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility in Texas

March 26, 2013 GlaxoSmithKline plc (GSK) and The Texas A&M University System announced today that the U.S. Department of Health and Human Services (DHHS) has approved the establishment of a $91...

World Tuberculosis Day: TB Drugs Round-Up

World Tuberculosis Day: TB Drugs Round-Up LONDON, UK (GlobalData), 22 March 2013 - As World Tuberculosis Day approaches, GlobalData takes a look at the latest medical innovations in the fight against...

Prevnar is Model for Blockbuster Vaccines

Prevnar is Model for Blockbuster Vaccines NEW YORK (GBI Research), 21 March 2013 Developing new vaccine products is a costly, lengthy and uncertain process, but the resounding success of the first...

Developing Countries Struggle to Finance and Enforce Tuberculosis Treatment, Leading to Drug-Resistant Super-Strains

Developing Countries Struggle to Finance and Enforce Tuberculosis Treatment, Leading to Drug-Resistant Super-Strains LONDON, UK (GlobalData), 21 March 2013 - Our approach towards tuberculosis (TB)...

Researchers advance fight against leading infectious cause of congenital birth defects

Researchers advance fight against leading infectious cause of congenital birth defects La Jolla Institute and Cardiff University discovery aids efforts toward cytomegalovirus vaccine SAN DIEGO...

Needle-Free Vaccine for Ear Infections Could Also Help Reduce Use of Antibiotics

Newswise — COLUMBUS, Ohio – Some types of ear infections may one day be as rare as polio and smallpox thanks to a vaccine that's being developed by a team of researchers at Nationwide...

Prokarium receives £0.4m grant to develop next generation vaccines

11 March 2013: A consortium comprising vaccine developer Prokarium Ltd and the University of Birmingham's Institute of Microbiology and Infection has received an award for 'advancing the...

Althea Technologies & Profectus BioSciences Sign Manufacturing Agreement For Plasmid DNA Production

SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of biopharmaceutical development and manufacturing services, and Profectus BioSciences Inc, a technology based...

New Bioterrorism Vaccine Gets First Test In Humans

NIAID Initiates Clinical Trial of STEBVax, a Staphylococcal Enterotoxin B Vaccine GAITHERSBURG, Md., Feb. 26, 2013 /PRNewswire/ -- Integrated BioTherapeutics (IBT) announces the initiation of a Phase...

European Medicines Agency Recommends Approval of Hexyon 6-in-1 Paediatric Vaccine

Upon approval Hexyon will be the only fully liquid, ready-to-use 6-in-1 paediatric vaccine in Europe Lyon, 22 February 2013 – Sanofi Pasteur MSD, the joint venture between MSD and Sanofi...